Viking Therapeutics' highly anticipated ... AstraZeneca said patients with type 2 diabetes lost 5.8% of their body weight over four weeks of treatment with its pill. And Corbus Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback